In addition, the AUC value of serum CEA and Cyfra21-1 were 0.7821 and 0.7968, respectively, and further confirm the ability of these serum to have diagnostic value for LC risk in HRR groups. This evidence concerns the gene CEACAM5 and laryngotracheoesophageal cleft.